Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background/Objectives: Inflammation serves as a vital response to diverse harmful stimuli like infections, toxins, or tissue injuries, aiding in the elimination of pathogens and tissue repair. However, persistent inflammation can lead to chronic diseases. Peptide therapeutics have gained attention for their specificity in targeting cells, yet their development remains costly and time-consuming. Therefore, small molecules, with their stability, low immunogenicity, and oral bioavailability, have become a focal point for predicting anti-inflammatory small molecules (AISMs). Methods: In this study, we introduce a computational method called AISMPred, designed to classify AISMs and non-AISMs. To develop this approach, we constructed a dataset comprising 1750 AISMs and non-AISMs, each annotated with IC50 values sourced from the PubChem BioAssay database. We computed two distinct types of molecular descriptors using PaDEL and Mordred tools. Subsequently, these descriptors were concatenated to form a hybrid feature set. The SVC-L1 regularization method was implemented for the optimum feature selection to develop robust Machine learning (ML) models. Five different conventional ML classifiers were employed, such as RF, ET, KNN, LR, and Ensemble methods. Results: A total of 15 ML models were developed using 2D, FP, and Hybrid feature sets, with the ET model with hybrid features achieving the highest accuracy of 92% and an AUC of 0.97 on the independent test dataset. Conclusions: This study provides an effective method for screening AISMs, potentially impacting drug discovery and design.
Background/Objectives: Inflammation serves as a vital response to diverse harmful stimuli like infections, toxins, or tissue injuries, aiding in the elimination of pathogens and tissue repair. However, persistent inflammation can lead to chronic diseases. Peptide therapeutics have gained attention for their specificity in targeting cells, yet their development remains costly and time-consuming. Therefore, small molecules, with their stability, low immunogenicity, and oral bioavailability, have become a focal point for predicting anti-inflammatory small molecules (AISMs). Methods: In this study, we introduce a computational method called AISMPred, designed to classify AISMs and non-AISMs. To develop this approach, we constructed a dataset comprising 1750 AISMs and non-AISMs, each annotated with IC50 values sourced from the PubChem BioAssay database. We computed two distinct types of molecular descriptors using PaDEL and Mordred tools. Subsequently, these descriptors were concatenated to form a hybrid feature set. The SVC-L1 regularization method was implemented for the optimum feature selection to develop robust Machine learning (ML) models. Five different conventional ML classifiers were employed, such as RF, ET, KNN, LR, and Ensemble methods. Results: A total of 15 ML models were developed using 2D, FP, and Hybrid feature sets, with the ET model with hybrid features achieving the highest accuracy of 92% and an AUC of 0.97 on the independent test dataset. Conclusions: This study provides an effective method for screening AISMs, potentially impacting drug discovery and design.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.